These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20138962)

  • 1. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells.
    Lappano R; Rosano C; De Marco P; De Francesco EM; Pezzi V; Maggiolini M
    Mol Cell Endocrinol; 2010 May; 320(1-2):162-70. PubMed ID: 20138962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
    Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
    Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.
    Sirianni R; Chimento A; Ruggiero C; De Luca A; Lappano R; Andò S; Maggiolini M; Pezzi V
    Endocrinology; 2008 Oct; 149(10):5043-51. PubMed ID: 18566133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
    Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
    Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
    Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S
    J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.
    Girgert R; Emons G; Gründker C
    BMC Cancer; 2014 Dec; 14():935. PubMed ID: 25496649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
    Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
    Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
    Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17 beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alpha.
    Chimento A; Sirianni R; Delalande C; Silandre D; Bois C; Andò S; Maggiolini M; Carreau S; Pezzi V
    Mol Cell Endocrinol; 2010 May; 320(1-2):136-44. PubMed ID: 20132863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis.
    Haas E; Meyer MR; Schurr U; Bhattacharya I; Minotti R; Nguyen HH; Heigl A; Lachat M; Genoni M; Barton M
    Hypertension; 2007 Jun; 49(6):1358-63. PubMed ID: 17452498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-α and -β.
    Perkins MS; Louw-du Toit R; Africander D
    J Steroid Biochem Mol Biol; 2017 Nov; 174():27-39. PubMed ID: 28743541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines.
    Diller M; Schüler S; Buchholz S; Lattrich C; Treeck O; Ortmann O
    Maturitas; 2014 Apr; 77(4):336-43. PubMed ID: 24529907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalein suppresses 17-β-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway.
    Shang D; Li Z; Zhu Z; Chen H; Zhao L; Wang X; Chen Y
    Oncol Rep; 2015 Apr; 33(4):2077-85. PubMed ID: 25672442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway.
    Zhang Y; Wei F; Zhang J; Hao L; Jiang J; Dang L; Mei D; Fan S; Yu Y; Jiang L
    Arch Biochem Biophys; 2017 Nov; 633():29-39. PubMed ID: 28882636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
    Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cell line competence for studies of pharmacological GPR30 modulation.
    Sousa C; Ribeiro M; Rufino AT; Leitão AJ; Mendes AF
    J Recept Signal Transduct Res; 2017 Apr; 37(2):181-188. PubMed ID: 27401115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.
    Madeo A; Maggiolini M
    Cancer Res; 2010 Jul; 70(14):6036-46. PubMed ID: 20551055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPER Mediates Non-Genomic Effects of Estrogen.
    Pupo M; Maggiolini M; Musti AM
    Methods Mol Biol; 2016; 1366():471-488. PubMed ID: 26585158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.